Senseonics Holdings, Inc.
General ticker "SENS" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $303.3M (TTM average)
Senseonics Holdings, Inc. follows the US Stock Market performance with the rate: 35.5%.
Estimated limits based on current volatility of 3.7%: low 7.87$, high 8.48$
Factors to consider:
- Total employees count: 130 (+11.1%) as of 2025
- US accounted for 79.2% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Operating losses, Regulatory and compliance, Manufacturing supply, Clinical trial delays, Liquidity and credit risks
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.97$, 7.91$]
- 2026-12-31 to 2027-12-31 estimated range: [2.34$, 6.33$]
Financial Metrics affecting the SENS estimates:
- Negative: with PPE of -3.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: 42.26 < Shareholder equity ratio, % of 48.35 <= 49.86
- Negative: negative Net income
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: -40.59 < Investing cash flow per share per price, % of -21.74
- Positive: Interest expense per share per price, % of 2.01 <= 2.54
- Negative: negative Industry operating cash flow (median)
Short-term SENS quotes
Long-term SENS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $22.39MM | $22.47MM | $35.26MM |
| Operating Expenses | $97.99MM | $97.31MM | $103.59MM |
| Operating Income | $-75.60MM | $-74.84MM | $-68.34MM |
| Non-Operating Income | $15.21MM | $-3.77MM | $-0.78MM |
| Interest Expense | $11.11MM | $8.44MM | $4.95MM |
| R&D Expense | $48.75MM | $41.14MM | $31.59MM |
| Income(Loss) | $-60.39MM | $-78.62MM | $-69.11MM |
| Net Income(Loss)* | $-60.39MM | $-78.62MM | $-69.11MM |
| Stockholders Equity | $35.80MM | $-16.55MM | $61.05MM |
| Inventory | $8.78MM | $4.42MM | $6.70MM |
| Assets | $138.22MM | $100.44MM | $126.27MM |
| Operating Cash Flow | $-70.16MM | $-60.47MM | $-59.13MM |
| Capital expenditure | $0.35MM | $2.24MM | $1.12MM |
| Investing Cash Flow | $89.71MM | $32.84MM | $-53.42MM |
| Financing Cash Flow | $20.37MM | $26.83MM | $78.19MM |
| Earnings Per Share** | $-2.13 | $-2.50 | $-1.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.